Sponsored by Boston Scientific Corporation
evt | Article | October 2017 Supplement
evt | News | June 27, 2018
FDA Clears Embolx's Next-Generation Sniper Balloon Occlusion Microcatheter
June 28, 2018—Embolx, Inc. announced that the company has received 510(k) clearance from the US Food and Drug Administration (FDA) for its next-generation family of Sniper balloon occlusion microcatheters, which provide pressure-directed arterial embolization therapy.
evt | Article | September 2020
evt | Article | November 2019
evt | Article | November 2018
Predictions for Transradial Access Capabilities in the Near Future
A discussion of available technology for transradial access in patients with aortoiliac and infrainguinal disease, current limitations, and opportunities for the future.
By Young Joon (Fred) Kwon, MSE; Raghuram Posham, MD, MPA; Rahul S. Patel, MD, FSIR; and Aaron Fischman, MD, FSIR, FCIRSE